Butylscopolamine bromide | CAS#149-64-4 | antimuscarinic quaternary ammonium derivative of scopolamine

MedKoo Cat#: 596281 | Name: Butylscopolamine bromide

Featured

Description:

WARNING: This product is for research use only, not for human or veterinary use.

Butylscopolamine bromide is an antimuscarinic quaternary ammonium derivative of scopolamine used to treat cramps in gastrointestinal, urinary, uterine, and biliary tracts, and to facilitate radiologic visualization of the gastrointestinal tract.

Chemical Structure

Butylscopolamine bromide

CAS#149-64-4

Theoretical Analysis

MedKoo Cat#: 596281

Name: Butylscopolamine bromide

CAS#: 149-64-4

Chemical Formula: C21H30BrNO4

Exact Mass: 439.1358

Molecular Weight: 440.37

Elemental Analysis: C, 57.28; H, 6.87; Br, 18.14; N, 3.18; O, 14.53

Price and Availability

Size	Price	Availability	Quantity
1g	USD 285.00	2 Weeks
5g	USD 750.00	2 Weeks

Bulk Inquiry

Buy Now

Add to Cart

Related CAS #

No Data

Synonym

Butylscopolamine bromide; EINECS 205-744-1; Hyoscine butobromide; Scobro; Buscolysine; Amisepan; Tirantil; Hyoscine Butylbromide; Scopolamine Butylbromide; N-Butylscopolaminium Bromide; Buscopan; (−)-Scopolamine N-butyl bromide

IUPAC/Chemical Name

(1R,2R,5S,7R,9S)-9-butyl-7-((3-hydroxy-2-phenylpropanoyl)oxy)-9-methyl-3-oxa-9-azatricyclo[3.3.1.02,4]nonan-9-ium bromide

InChi Key

HOZOZZFCZRXYEK-RLBJRARZSA-M

InChi Code

InChI=1S/C21H30NO4.BrH/c1-3-4-10-22(2)17-11-15(12-18(22)20-19(17)26-20)25-21(24)16(13-23)14-8-6-5-7-9-14;/h5-9,15-20,23H,3-4,10-13H2,1-2H3;1H/q+1;/p-1/t15-,16?,17+,18-,19+,20?,22+;/m0./s1

SMILES Code

C[N@+]1(CCCC)[C@H]2C[C@@H](OC(C(C3=CC=CC=C3)CO)=O)C[C@@H]1[C@@H]4C2O4.[Br-]

Appearance

Solid powder

Purity

>98% (or refer to the Certificate of Analysis)

Shipping Condition

Shipped under ambient temperature as non-hazardous chemical. This product is stable enough for a few weeks during ordinary shipping and time spent in Customs.

Storage Condition

Dry, dark and at 0 - 4 C for short term (days to weeks) or -20 C for long term (months to years).

Solubility

Soluble in DMSO

Shelf Life

>2 years if stored properly

Drug Formulation

This drug may be formulated in DMSO

Stock Solution Storage

0 - 4 C for short term (days to weeks), or -20 C for long term (months).

HS Tariff Code

2934.99.9001

More Info

Instruction

View handling instruction

Preparing Stock Solutions

The following data is based on the product molecular weight 440.37 Batch specific molecular weights may vary from batch to batch due to the degree of hydration, which will affect the solvent volumes required to prepare stock solutions.

Concentration / Solvent Volume / Mass	1 mg	5 mg	10 mg
1 mM	1.15 mL	5.76 mL	11.51 mL
5 mM	0.23 mL	1.15 mL	2.3 mL
10 mM	0.12 mL	0.58 mL	1.15 mL
50 mM	0.02 mL	0.12 mL	0.23 mL

1: Madhoun MF, Ali T, Tierney WM, Maple JT. Effect of hyoscine N-butylbromide on adenoma detection rate: meta-analysis of randomized clinical trials. Dig Endosc. 2015 Mar;27(3):354-60. doi: 10.1111/den.12340. Epub 2014 Oct 16. Review. PubMed PMID: 25115416. 2: Cui PJ, Yao J, Han HZ, Zhao YJ, Yang J. Does hyoscine butylbromide really improve polyp detection during colonoscopy? A meta-analysis of randomized controlled trials. World J Gastroenterol. 2014 Jun 14;20(22):7034-9. doi: 10.3748/wjg.v20.i22.7034. Review. PubMed PMID: 24944499; PubMed Central PMCID: PMC4051948. 3: Papadopoulos G, Bourdoumis A, Kachrilas S, Bach C, Buchholz N, Masood J. Hyoscine N-butylbromide (Buscopan®) in the treatment of acute ureteral colic: what is the evidence? Urol Int. 2014;92(3):253-7. doi: 10.1159/000358015. Epub 2014 Feb 26. Review. PubMed PMID: 24576895. 4: Akram J, Amin FM, Toft JG, Rømeling F. [Treatment of foreign body impactions in oesophagus]. Ugeskr Laeger. 2013 Mar 4;175(10):640-3. Review. Danish. PubMed PMID: 23462035. 5: Klein C, Stiel S, Bükki J, Ostgathe C. [Pharmacological treatment of malignant bowel obstruction in severely ill and dying patients : a systematic literature review]. Schmerz. 2012 Sep;26(5):587-99. doi: 10.1007/s00482-012-1247-0. Review. German. PubMed PMID: 23052994. 6: Pastrana T, Reineke-Bracke H, Elsner F. [Recommendations for death rattle]. Schmerz. 2012 Sep;26(5):600-7. doi: 10.1007/s00482-012-1215-8. Review. German. PubMed PMID: 22956075. 7: Boellaard TN, de Haan MC, Venema HW, Stoker J. Colon distension and scan protocol for CT-colonography: an overview. Eur J Radiol. 2013 Aug;82(8):1144-58. doi: 10.1016/j.ejrad.2011.10.030. Epub 2011 Dec 7. Review. PubMed PMID: 22154604. 8: Leopard D, Fishpool S, Winter S. The management of oesophageal soft food bolus obstruction: a systematic review. Ann R Coll Surg Engl. 2011 Sep;93(6):441-4. doi: 10.1308/003588411X588090. Review. PubMed PMID: 21929913; PubMed Central PMCID: PMC3369328. 9: Tytgat GN. Hyoscine butylbromide - a review on its parenteral use in acute abdominal spasm and as an aid in abdominal diagnostic and therapeutic procedures. Curr Med Res Opin. 2008 Nov;24(11):3159-73. doi: 10.1185/03007990802472700 . Epub 2008 Oct 10. Review. PubMed PMID: 18851775. 10: Dyde R, Chapman AH, Gale R, Mackintosh A, Tolan DJ. Precautions to be taken by radiologists and radiographers when prescribing hyoscine-N-butylbromide. Clin Radiol. 2008 Jul;63(7):739-43. doi: 10.1016/j.crad.2008.02.008. Epub 2008 May 2. Review. PubMed PMID: 18555031. 11: Tytgat GN. Hyoscine butylbromide: a review of its use in the treatment of abdominal cramping and pain. Drugs. 2007;67(9):1343-57. Review. PubMed PMID: 17547475. 12: Anderson R, Lee J. Buscopan for oesophageal food bolus impaction. Emerg Med J. 2007 May;24(5):360-1. Review. PubMed PMID: 17452709; PubMed Central PMCID: PMC2658491. 13: Price T, Jones SE, Montgomery PQ. Is current UK management of oesophageal food bolus obstruction evidence based? An e-mail survey and literature review. Eur Arch Otorhinolaryngol. 2007 Apr;264(4):329-35. Epub 2007 Feb 14. Review. PubMed PMID: 17333232. 14: Mercadante S, Casuccio A, Mangione S. Medical treatment for inoperable malignant bowel obstruction: a qualitative systematic review. J Pain Symptom Manage. 2007 Feb;33(2):217-23. Review. PubMed PMID: 17280927. 15: Evangelista S. Quaternary ammonium derivatives as spasmolytics for irritable bowel syndrome. Curr Pharm Des. 2004;10(28):3561-8. Review. PubMed PMID: 15579053. 16: Mackway-Jones K, Teece S. Towards evidence based emergency medicine: best BETs from the Manchester Royal Infirmary. Buscopan (hyoscine butylbromide) in abdominal colic. Emerg Med J. 2003 May;20(3):267. Review. PubMed PMID: 12748151; PubMed Central PMCID: PMC1726111. 17: Ripamonti C, Panzeri C, Groff L, Galeazzi G, Boffi R. The role of somatostatin and octreotide in bowel obstruction: pre-clinical and clinical results. Tumori. 2001 Jan-Feb;87(1):1-9. Review. PubMed PMID: 11669548. 18: Begemann P, Erbersdobler A, Maas R. [Actinomycosis and chronic pancreatitis]. Rofo. 1999 Aug;171(2):170-2. Review. German. PubMed PMID: 10506896. 19: Boiteux JP. [Graphic interpretation of pressure-flow analysis]. Prog Urol. 1998 Dec;8(6):1065-73. Review. French. Erratum in: Prog Urol 1999 Feb;9(1):13. PubMed PMID: 9894271. 20: Sheptulin AA. [Current potentialities of Buscopan in clinical practice]. Klin Med (Mosk). 1997;75(8):55-7. Review. Russian. PubMed PMID: 9340442.